JP2023518356A5 - - Google Patents
Info
- Publication number
- JP2023518356A5 JP2023518356A5 JP2022554956A JP2022554956A JP2023518356A5 JP 2023518356 A5 JP2023518356 A5 JP 2023518356A5 JP 2022554956 A JP2022554956 A JP 2022554956A JP 2022554956 A JP2022554956 A JP 2022554956A JP 2023518356 A5 JP2023518356 A5 JP 2023518356A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- patient
- active ingredient
- fostamatinib
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062988876P | 2020-03-12 | 2020-03-12 | |
| US62/988,876 | 2020-03-12 | ||
| US202063038570P | 2020-06-12 | 2020-06-12 | |
| US63/038,570 | 2020-06-12 | ||
| PCT/US2021/021951 WO2021183790A1 (en) | 2020-03-12 | 2021-03-11 | Method for treatment of covid-19-associated conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518356A JP2023518356A (ja) | 2023-05-01 |
| JP2023518356A5 true JP2023518356A5 (https=) | 2024-03-21 |
Family
ID=77665493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554956A Pending JP2023518356A (ja) | 2020-03-12 | 2021-03-11 | Ｃｏｖｉｄ－１９関連状態の治療のための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12263180B2 (https=) |
| EP (1) | EP4117728A4 (https=) |
| JP (1) | JP2023518356A (https=) |
| KR (1) | KR20220152293A (https=) |
| CN (1) | CN115768474A (https=) |
| AU (1) | AU2021234316A1 (https=) |
| BR (1) | BR112022018235A2 (https=) |
| CA (1) | CA3175089A1 (https=) |
| IL (1) | IL296352A (https=) |
| JO (1) | JOP20220218A1 (https=) |
| MX (1) | MX2022011278A (https=) |
| PE (1) | PE20230996A1 (https=) |
| PH (1) | PH12022552539A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023194840A1 (en) | 2022-04-05 | 2023-10-12 | Unichem Laboratories Limited | Substituted tricyclic compounds and their use in covid-19 |
| CN116440117A (zh) * | 2023-06-14 | 2023-07-18 | 四川省医学科学院·四川省人民医院 | 甲磺酸萘莫司他在制备治疗肾损伤或肾功能不全药物中的应用 |
| CN116650507A (zh) * | 2023-06-28 | 2023-08-29 | 中国人民解放军军事科学院军事医学研究院 | 福它替尼在制备治疗放射性肺纤维化药物中的应用 |
| CN118649237A (zh) * | 2024-06-13 | 2024-09-17 | 高维医药(杭州)有限公司 | S蛋白或p4hb蛋白作为靶点在制备预防或治疗新冠感染相关性凝血病变的药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| HRP20050089B1 (hr) | 2002-07-29 | 2015-06-19 | Rigel Pharmaceuticals | Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti |
| ATE540041T1 (de) | 2006-11-21 | 2012-01-15 | Rigel Pharmaceuticals Inc | Prodrug-salze von 2,4-pyrimidindiaminverbindungen und anwendungen davon |
| UA102825C2 (ru) | 2007-11-07 | 2013-08-27 | Райджел Фармасьютикалз, Инк. | Фармацевтическая композиция, полученная влажным гранулированием с использованием вещества, которое связывает воду |
| WO2015116729A2 (en) * | 2014-01-28 | 2015-08-06 | Emergent Product Development Seattle, Llc | Anti-cd37 antibody and anti-cd20 antibody combination therapy for treatment of b-cell malignancies and disorders |
| US20160060260A1 (en) * | 2014-08-29 | 2016-03-03 | Board Of Regents, The University Of Texas System | Bromodomain inhibitors for treating disease |
| WO2018002311A1 (en) * | 2016-06-30 | 2018-01-04 | Siess Wolfgang | Treatment and prevention of atherothrombosis by inhibition of syk kinase |
| GB202005890D0 (en) * | 2020-04-22 | 2020-06-03 | Aivivo Ltd | New uses |
-
2021
- 2021-03-11 CA CA3175089A patent/CA3175089A1/en active Pending
- 2021-03-11 BR BR112022018235A patent/BR112022018235A2/pt unknown
- 2021-03-11 IL IL296352A patent/IL296352A/en unknown
- 2021-03-11 PE PE2022001945A patent/PE20230996A1/es unknown
- 2021-03-11 JO JOP/2022/0218A patent/JOP20220218A1/ar unknown
- 2021-03-11 KR KR1020227035071A patent/KR20220152293A/ko active Pending
- 2021-03-11 CN CN202180034971.6A patent/CN115768474A/zh active Pending
- 2021-03-11 JP JP2022554956A patent/JP2023518356A/ja active Pending
- 2021-03-11 PH PH1/2022/552539A patent/PH12022552539A1/en unknown
- 2021-03-11 AU AU2021234316A patent/AU2021234316A1/en active Pending
- 2021-03-11 EP EP21768322.6A patent/EP4117728A4/en active Pending
- 2021-03-11 MX MX2022011278A patent/MX2022011278A/es unknown
- 2021-05-18 US US17/323,901 patent/US12263180B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518356A5 (https=) | ||
| JP2021098728A5 (https=) | ||
| JP2017528507A5 (https=) | ||
| Lee et al. | The plain chest radiograph after acute smoke inhalation | |
| Wood | Thoracic trauma | |
| JP2024541569A5 (https=) | ||
| Boat et al. | Pneumothorax in cystic fibrosis | |
| Samson et al. | Tuberculous tracheobronchitis | |
| Dudley et al. | Pulmonary overlap syndromes, with a focus on COPD and ILD | |
| Holinger et al. | THE INFLUENCE OF EXPECTORANTS AND GASES: ON SPUTUM AND THE MUCOUS MEMBRANES OF THE TRACHEOBRONCHIAL TREE | |
| AU2020348813B2 (en) | Uses of complex of angiotensin II receptor antagonist metabolite and NEP inhibitor in treating heart failure | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| WO2023156808A3 (en) | Compositions and methods for treating pulmonary disorders | |
| JPWO2023163203A5 (https=) | ||
| Kunwar et al. | A comparative study of efficacy of dexamethasone and Mgso4 preoperative nebulisation in reduction of post operative sore throat following general anaesthesia | |
| RU2253484C1 (ru) | Способ лечения хронического бронхолегочного процесса при врожденных пороках развития легких у детей | |
| Jasani et al. | Effect of coronary artery bypass grafting surgery on pulmonary function tests and arterial blood gases | |
| Waldbott | Bronchoscopic therapy in allergic asthma | |
| JP6021952B2 (ja) | 慢性閉塞性肺疾患の治療法 | |
| Yadu et al. | Effect of chest physiotherapy on the prevention of ventilator-associated pneumonia and mortality | |
| CN105326789B (zh) | 氨溴索沙丁胺醇溶液剂 | |
| Harrington | The surgical treatment of bronchiectasis and lung abscess | |
| Gray | Atelectasis as a complication of pulmonary lobectomy | |
| Alcantara et al. | Cesarean section under epidural analgesia in a parturient with mitral valve prolapse | |
| WO2024192149A3 (en) | Method of treating enterovirus in chronic obstructive pulmonary disease patients |